+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The tag Porcine Reproductive And Respiratory Syndrome Vaccine returned 0 results.

No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.

The Porcine Reproductive and Respiratory Syndrome Vaccine (PRRSV) is a vaccine used to protect pigs from the Porcine Reproductive and Respiratory Syndrome (PRRS) virus. PRRS is a highly contagious viral disease that affects the reproductive and respiratory systems of pigs, causing significant economic losses to the swine industry. The PRRSV vaccine is used to reduce the severity of the disease and to reduce the spread of the virus. The PRRSV vaccine market is a part of the larger animal pharmaceuticals market, which includes a variety of products used to treat and prevent diseases in animals. The PRRSV vaccine market is growing due to the increasing prevalence of the PRRS virus and the need for effective control measures. The market is also driven by the increasing demand for animal-derived products, such as meat and dairy, and the need to ensure the health and safety of these products. Some of the major companies in the PRRSV vaccine market include Merck Animal Health, Zoetis, Boehringer Ingelheim, Elanco, and Ceva Animal Health. Show Less Read more